Restructuring Charges and Other Costs Associated with Acquisitions and Cost-Reduction/Productivity Initiatives - Schedule of Acquisitions and Cost-Reduction/Productivity Initiatives (Detail) - USD ($) $ in Millions |
3 Months Ended | 24 Months Ended | 30 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 29, 2026 |
Mar. 30, 2025 |
Mar. 29, 2026 |
Mar. 29, 2026 |
|||||||||
| Restructuring charges/(credits): | ||||||||||||
| Employee terminations | $ 15 | $ 384 | ||||||||||
| Asset impairments | 28 | 173 | ||||||||||
| Exit costs | 6 | 64 | ||||||||||
| Restructuring charges/(credits) | [1] | 49 | 621 | |||||||||
| Integration costs and other | [2] | 51 | 57 | |||||||||
| Restructuring charges and certain acquisition-related costs | 100 | 678 | ||||||||||
| Additional depreciation––asset restructuring recorded in Cost of sales | [3] | 3 | 4 | |||||||||
| Implementation costs | [4] | 89 | 50 | |||||||||
| Total costs associated with acquisitions and cost-reduction/productivity initiatives | 195 | 673 | ||||||||||
| Biopharma [Member] | ||||||||||||
| Restructuring charges/(credits): | ||||||||||||
| Restructuring charges/(credits) | 31 | 617 | ||||||||||
| Biopharma [Member] | Manufacturing Optimization Program [Member] | ||||||||||||
| Restructuring charges/(credits): | ||||||||||||
| Restructuring charges/(credits) | (22) | (4) | $ 853 | |||||||||
| Biopharma [Member] | Realigning Our Cost Base Program [Member] | ||||||||||||
| Restructuring charges/(credits): | ||||||||||||
| Restructuring charges/(credits) | 47 | 587 | $ 2,900 | |||||||||
| Other (income)/deductions––net [Member] | ||||||||||||
| Restructuring charges/(credits): | ||||||||||||
| Net periodic benefit costs/(credits) recorded in Other (income)/deductions––net | 3 | (59) | ||||||||||
| Cost of sales [Member] | ||||||||||||
| Restructuring charges/(credits): | ||||||||||||
| Implementation costs | [4] | 15 | 20 | |||||||||
| Selling, informational and administrative expenses [Member] | ||||||||||||
| Restructuring charges/(credits): | ||||||||||||
| Implementation costs | [4] | 36 | 6 | |||||||||
| Research and development expenses [Member] | ||||||||||||
| Restructuring charges/(credits): | ||||||||||||
| Implementation costs | [4] | $ 38 | $ 24 | |||||||||
| ||||||||||||